OBJECTIVE
To assess the toxicity, pathologic response rates, type of surgery, and oncologic results in a prospective Phase I-II trial using pure hyperfractionated radiotherapy (RT) preoperatively in locally advanced rectal cancer.
METHODS
Between September 1997 and April 2000, 50 patients with T3-T4